ObjectiveTo explore the efficacy of group cognitive-behavioral therapy(GCBT) for diabetic patients with anxiety and depression.
MethodsIn this randomized control study, 42 patients was recruited for treatment of diabetes and allocated them in a randomized manner (1:1) into two groups to receive either 10-weeks GCBT plus regular education or regular education alone.Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Self-rating Depression Scale(SDS), and fasting blood glucose were measured and evaluated before and after treatment.
ResultsAfter 10 weeks of intervention, the total scores of HAMD, HAMA, and SDS were significantly decreased.Compared with the control group, repeated measures of ANOVA revealed a significant group-by-time interaction(F=6.801, 10.30, 5.02, P=0.013, 0.003, 0.031).The difference of HAMD was negatively correlated with disease duration and education (r=-0.486, -0.541, P=0.030, 0.014), and the difference of SDS was obviously correlated with gender, as the SDS score of women decreased more significantly (r=0.582, P=0.007).
ConclusionGroup cognitive-behavioral therapy can help to improve the mood of diabetic patients with anxiety and depression, rehabilitating their social function and life quality.
DownLoad: